We are live on
!
Find out more
EMB
Elefante Mark B Portfolio holdings
AUM
$182M
1-Year Est. Return
17.71%
This Fund
S&P 500
This Quarter
Est. Return
+4.09%
1 Year Est. Return
+17.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.26M
AUM Growth
+$2.54M
(+68%)
Cap. Flow
+$2.31M
Cap. Flow
% of AUM
36.94%
Top 10 Holdings %
Top 10 Hldgs %
62.13%
Holding
20
New
6
Increased
13
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$303K |
| 2 |
Chubb
CB
|
+$221K |
| 3 |
PepsiCo
PEP
|
+$221K |
| 4 |
ExxonMobil
XOM
|
+$217K |
| 5 |
SLB Ltd
SLB
|
+$216K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rockwell Automation
ROK
|
+$1.01K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.87% |
| 2 | Technology | 23.05% |
| 3 | Industrials | 13.57% |
| 4 | Financials | 9.64% |
| 5 | Consumer Staples | 9.29% |
Similar funds
CIA
HWM
AFS
TFP
CFG
CFG
NED
RS
Elefante Mark B's Q1 2016 Portfolio in Review
As of Q1 2016, Elefante Mark B held 20 positions worth $6.26M, up 68% from $3.72M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Elefante Mark B deployed $2.31M of net new capital in Q1 2016, opening 6 new positions and adding to 13 existing holdings. Its largest new stake was 3M: 2,362 shares worth $329K.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Rockwell Automation, an estimated $1.01K trimmed.
- Elefante Mark B's largest Q1 2016 buy was 3M: 2,362 shares worth $329K.
- Elefante Mark B added most to CVS Health in Q1 2016, an estimated $192K increase.
- Elefante Mark B's biggest Q1 2016 reduction was Rockwell Automation, cutting an estimated $1.01K.
- Elefante Mark B's ten largest holdings make up 62% of its $6.26M portfolio in Q1 2016.
- Elefante Mark B opened 6 new positions and closed 0 in Q1 2016.
- Elefante Mark B's portfolio value rose 68% quarter-over-quarter to $6.26M.
Based on Elefante Mark B's 13F filing for Q1 2016, filed 27 May 2016.